[1]
Borrás-Blasco, J. , Valcuende-Rosique, A. , Rosique-Robles, D. and Casterá, E. 2022. Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up. Journal of Pharmacy and Nutrition Sciences . 12, (Dec. 2022), 74–79. DOI:https://doi.org/10.29169/1927-5951.2022.12.06.